GH•benzinga•
Why Is Cancer Diagnostic Guardant Health Stock Trading Higher On Tuesday?
Summary
Guardant Health's Shield test receives FDA breakthrough status and NCCN guideline inclusion, with high accuracy shown in new ASCO and ECLIPSE study data.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 3, 2025 by benzinga